C F Bryan - JoVE Visualize

Showing results (21-30 of 33) with videos related to

Pageof 4

Sort By:

Journal of Clinical Immunology|March 1, 1984

Thermostable erythrocyte rosette-forming lymphocytes in hereditary hemochromatosis. I. Identification in peripheral bloodC F Bryan, S H Leech, R Ducos, et al.

Tissue Antigens|October 6, 2000

HLA-B*4012: a new allele with unique serological featuresH A Elsner, B J O'Brien, C F Bryan, et al.

Clinical Transplantation|June 11, 2003

Point-of-care testing in an organ procurement organization donor management settingK A Baier, L E Markham, S P Flaigle, et al.

Transplantation|December 27, 1995

Detection of HLA IgG antibodies by two enzyme-linked immunoassays, solubilized HLA class I and PRA-STAT. Comparison with the AHG PRAC F Bryan, K A Baier, G Flora-Ginter, et al.

Kidney International|September 1, 1994

Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: a U.S. National Collaborative StudyB J Pereira, T L Wright, C H Schmid, et al.

Clinical Transplantation|February 29, 2000

Successful cadaveric renal transplantation of patients highly sensitized to HLA Class I antigensC F Bryan, C F Shield, G E Pierce, et al.

Transplantation|May 15, 2001

Cold ischemia time: an independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograftC F Bryan, A M Luger, J Martinez, et al.

Transplantation|December 27, 1996

HLA-DR and DQ typing by polymerase chain reaction using sequence-specific primer mixes reduces the incidence of phenotypic homozygosity (blanks) over serologyC F Bryan, K M Harrell, P W Nelson, et al.

Transplantation|January 12, 1999

Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatchingC F Bryan, K A Baier, P W Nelson, et al.

Clinical Transplantation|March 21, 2002

IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotypeC F Bryan, J Martinez, N Muruve, et al.

Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:

Pageof 4

Journal of Clinical Immunology|March 1, 1984

Thermostable erythrocyte rosette-forming lymphocytes in hereditary hemochromatosis. I. Identification in peripheral bloodC F Bryan, S H Leech, R Ducos, et al.

Tissue Antigens|October 6, 2000

HLA-B*4012: a new allele with unique serological featuresH A Elsner, B J O'Brien, C F Bryan, et al.

Clinical Transplantation|June 11, 2003

Point-of-care testing in an organ procurement organization donor management settingK A Baier, L E Markham, S P Flaigle, et al.

Transplantation|December 27, 1995

Detection of HLA IgG antibodies by two enzyme-linked immunoassays, solubilized HLA class I and PRA-STAT. Comparison with the AHG PRAC F Bryan, K A Baier, G Flora-Ginter, et al.

Kidney International|September 1, 1994

Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: a U.S. National Collaborative StudyB J Pereira, T L Wright, C H Schmid, et al.

Clinical Transplantation|February 29, 2000

Successful cadaveric renal transplantation of patients highly sensitized to HLA Class I antigensC F Bryan, C F Shield, G E Pierce, et al.

Transplantation|May 15, 2001

Cold ischemia time: an independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograftC F Bryan, A M Luger, J Martinez, et al.

Transplantation|December 27, 1996

HLA-DR and DQ typing by polymerase chain reaction using sequence-specific primer mixes reduces the incidence of phenotypic homozygosity (blanks) over serologyC F Bryan, K M Harrell, P W Nelson, et al.

Transplantation|January 12, 1999

Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatchingC F Bryan, K A Baier, P W Nelson, et al.

Clinical Transplantation|March 21, 2002

IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotypeC F Bryan, J Martinez, N Muruve, et al.

Pageof 4